The company is still headquartered in Chicago. The company was called Abbott Laboratories for many years before taking the AbbVie name in 2012.

Broader macroeconomic uncertainty has resulted in continued cautiousness for both investors and acquirers in the in vitro ...

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Every investor in Abbott Laboratories (NYSE:ABT) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 81% ownership. In ...

Backed by a multimillion-dollar war chest, digital transformation and data intelligence consultancy Bailey Abbott has made ...

The governor directed lawmakers to redraw the state’s congressional boundaries, an effort President Donald Trump has been ...

Today we will run through one way of estimating the intrinsic value of Abbott Laboratories (NYSE:ABT) by projecting its future cash flows and then discounting them to today's value. This will be ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie.